scispace - formally typeset
Search or ask a question

Showing papers in "Journal of AOAC International in 1992"


Journal ArticleDOI
TL;DR: The report presents the assessment of the major agreements and issues discussed at the conference on analytical methods validation and provides guiding principles for validation of analytical methods used in bioavailability, bioequivalence, and pharmacokinetics studies in humans and animals.
Abstract: 0 This is a summary report of the conference on "Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies." The conference was held from December 3 to 5,1990, in the Washington, D.C., area and was sponsored by the American Association of Pharmaceutical Scientists, the US. Food and Drug Administration, Federation International Pharmaceutique, Health Protection Branch (Canada), and the Association of Official Analytical Chemists. The report presents our assessment of the major agreements and issues discussed at the conference. The report is also intended to provide guiding principles for validation of analytical methods used in bioavailability, bioequivalence, and pharmacokinetics studies in humans and animals. The objectives of the conference were as follows: (1) to reach a consensus on what should be required in analytical methods validation and the procedures to establish validation; (2) to determine processes of application of the validation procedures in bioavailability, bioequivalence, and pharmacokinetics studies; and (3) to develop a report on analytical methods validation that may be referred to in developing future formal guidelines. Acceptable standards for documenting and validating analytical methods with regard to processes, parameters, or data treatments are discussed because of their importance in assessing pharmacokinetic, bioavailability, and bioequivalence studies. Other topics that were considered essential in the conduct of pharmacokinetic studies or in establishing bioequivalency criteria, including measurement of drug metabolites and stereoselective determinations, are also discussed. ___ -. ~. ~ _ _ Analytical methods that are used for the quantitative determination of drugs and their metabolites in biological samples play a significant role in evaluation and interpretation of bioavailability, bioequivalence, and pharmacokinetic data. It is essential to use well-characterized and fully validated analytical methods to yield reliable results that can be satisfactorily interpreted. Analytical methods and techniques are constantly being changed and improved; in many instances, these methods are at the cutting edge of the technology. It is also important to emphasize that each analytical technique has its own characteristics, which will vary from drug to drug. Moreover, the appropriateness of the technique may be influenced by the ultimate objective of the study. Specific validation criteria are needed for methods intended for analysis of each analyte (drug and/or metabolite). Although validation of each method will be independent of those of other methods, there may be situations in which comparison of the methods will be necessary (e.g., when more than one method has been used in a long-term study). When sample analysis is conducted at more than one site, it is necessary to validate the analytical methodb) at each site and provide appropriate validation information for different sites to establish interlaboratory reliability. Unless a method is used on a regular basis, providing confidence in its continued validity, it is essential to document that the method is still valid before analysis of samples in the study. Adequate validation for methods not used on a regular basis often consists of running a standard curve with new quality-control samples to show that the responses, relationship, and general characteristics of the method are similar to previous valida-

582 citations




















Journal ArticleDOI
TL;DR: In this paper, the heavy metals of toxicological concern, lead and cadmium, were reported to be rarely detected in muscle (0.2-0.5% positive among 2314 animals sampled) and liver (1.8% positive) and kidney (2.4% positive).
Abstract: Data from a random-sampling study are presented for trace metals in edible tissues of livestock (bovine including bull, steer, cow heifer, calf; ovine including bull, steer, cow, heifer, calf; ovine including mature sheep and lambs; porcine including market hogs, boar/stag, and slow) and poultry (including young and mature chicken, young turkey, and duck). Tissue homogenates were ashed, and residual materials were dissolved in hydrochloric acid for analysis by atomic absorption spectroscopy. Statistical summaries of data are provided for the trace metals lead, cadmium, cobalt, copper, iron, manganese, nickel, and zinc. The heavy metals of toxicological concern, lead and cadmium, are emphasized in this study. Lead and cadmium were rarely detected in muscle (0.2-0.5% positive among 2314 animals sampled). Lead was also infrequently detected in liver (1.8% positive) and kidney (2.4% positive). Nearly 46% of livers analyzed were positive for cadmium, and approximately 78 of kidney samples were positive for cadmium. No regulatory limits are established in the United States for the trace metals reported in this study, although restrictions on the use of kidneys from mature poultry as human food have been established because of concern about potential cadmium levels. Kidneys from this study, more frequently than livers, bore cadmiummore » levels that exceeded the regulatory limits of other countries or organizations. Regulatory implications of the data are discussed. 23 refs., 7 tabs.« less